Percutaneous transluminal coronary angioplasty (PTCA) with drug-eluting balloon (DEB) in patients with coronary artery disease (CAD). 3rd Update

Semlitsch T, Krenn C
Record ID 32018013186
English
Authors' objectives: Arteriosclerosis is defined as the narrowing of blood vessels due to the accumulation of plaque deposits. When this occurs in the coronary arteries, it is referred to as coronary artery disease (CAD). In this context, percutaneous transluminal coronary angioplasty (PTCA) with a drug-eluting balloon (DEB) represents a novel treatment method and an alternative to other treatment methods, such as uncoated balloon catheters or stent implantations. The Austrian Institute for Health Technology Assessment (AIHTA) conducted a systematic review to analyze the comparative evidence of PTCA with DEB.
Authors' results and conclusions: The analysis yielded evidence suggesting an additional benefit in certain indications, particularly in cases of in-stent restenosis (ISR).
Details
Project Status: Completed
Year Published: 2024
URL for additional information: https://eprints.aihta.at/1528/
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: Austria
MeSH Terms
  • Coronary Artery Disease
  • Percutaneous Coronary Intervention
  • Angioplasty, Balloon, Coronary
  • Drug-Eluting Stents
  • Coronary Stenosis
  • Coronary Restenosis
  • Atherosclerosis
Keywords
  • Coronary artery disease
  • percutaneous intervention
  • balloon angioplasty
  • stent
Contact
Organisation Name: Austrian Institute for Health Technology Assessment
Contact Address: Garnisongasse 7/20, A-1090 Vienna, Austria
Contact Name: office@aihta.at
Contact Email: office@aihta.at
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.